Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome
Authors:
- Jos F FrenckenJFJos F Frencken
- Dirk W DonkerDDDirk W Donker
- Cristian SpitoniCSCristian Spitoni
- Marlies E Koster-BrouwerMKMarlies E Koster-Brouwer
- Ivo W SolimanISIvo W Soliman
- David S Y OngDODavid S Y Ong
- Janneke HornJHJanneke Horn
- Tom Van Der PollTPTom Van Der Poll
- Wilton A Van KleiWKWilton A Van Klei
- Marc J M BontenMBMarc J M Bonten
- Olaf L CremerOCOlaf L Cremer
- 1 February 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 11 (2) , e004040
Abstract
Background: Sepsis is frequently complicated by the release of cardiac troponin, but the clinical significance of this myocardial injury remains unclear. We studied the associations between troponin release during sepsis and 1-year outcomes. Methods and Results: We enrolled consecutive patients with sepsis in 2 Dutch intensive care units between 2011 and 2013. Subjects with a clinically apparent cause of troponin release were excluded. High-sensitivity cardiac troponin I (hs-cTnI) concentration in plasma was measured daily during the first 4 intensive care unit days, and multivariable Cox regression analysis was used to model its association with 1-year mortality while adjusting for confounding. In addition, we studied cardiovascular morbidity occurring during the first year after hospital discharge. Among 1258 patients presenting with sepsis, 1124 (89%) were eligible for study inclusion. Hs-cTnI concentrations were elevated in 673 (60%) subjects on day 1, and 755 (67%) ever had elevated levels in the first 4 days. Cox regression analysis revealed that high hs-cTnI concentrations were associated with increased death rates during the first 14 days (adjusted hazard ratio, 1.72; 95% confidence interval, 1.14–2.59 and hazard ratio, 1.70; 95% confidence interval, 1.10–2.62 for hs-cTnI concentrations of 100–500 and >500 ng/L, respectively) but not thereafter. Furthermore, elevated hs-cTnI levels were associated with the development of cardiovascular disease among 200 hospital survivors who were analyzed for this end point (adjusted subdistribution hazard ratio, 1.25; 95% confidence interval, 1.04–1.50). Conclusions: Myocardial injury occurs in the majority of patients with sepsis and is independently associated with early—but not late—mortality, as well as postdischarge cardiovascular morbidity.Keywords
This publication has 37 references indexed in Scilit:
- Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrineCritical Care, 2013
- Clinical Spectrum, Frequency, and Significance of Myocardial Dysfunction in Severe Sepsis and Septic ShockMayo Clinic Proceedings, 2012
- Cardiac troponin I does not independently predict mortality in critically ill patients with severe sepsisEmergency Medicine Australasia, 2012
- Routine health insurance data for scientific research: potential and limitations of the Agis Health DatabaseJournal of Clinical Epidemiology, 2011
- Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcomeIntensive Care Medicine, 2010
- The Hazards of Hazard RatiosEpidemiology, 2010
- Selection of important variables and determination of functional form for continuous predictors in multivariable model buildingStatistics in Medicine, 2007
- Statin use after acute myocardial infarction: a nationwide study in DenmarkBritish Journal of Clinical Pharmacology, 2005
- Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shockInternational Journal of Cardiology, 2004
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992